Last reviewed · How we verify

NCT04169425

Laparoscopic Surgery of Rectal Cancer and Ileostomy

Completed Last updated 21 November 2019
What this trial tests

trial testing elective diverting ileostomy in Ileostomy - Stoma in 150 participants. Completed in 1 February 2018.

Timeline
2 January 2012
Primary endpoint
22 December 2017
1 February 2018

Quick facts

Lead sponsorCampus Bio-Medico University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment150
Start date2 January 2012
Primary completion22 December 2017
Estimated completion1 February 2018

Drugs / interventions tested

Conditions studied

Sponsor

Campus Bio-Medico University

Who can join

Adults 67 to 86, any sex, with Ileostomy - Stoma or Ileostomy; Complications. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Elective diverting ileostomy may reduce consequences of anastomotic failure in laparoscopic TME. Aiming to evaluate the effectiveness of elective diverting ileostomy, its impact on the incidence and clinical behavior of anastomotic leakage and the complications related to its presence and take down were analyzed.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Ileostomy - Stoma

Currently open trials in the same condition.

Other Campus Bio-Medico University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04169425.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing